At the news
? BULLISHIMPACT 7/10 PRESS-RELEASE filed Aug 5, 2026 at 16:20 ET
Encompass Health reported Q2 2026 diluted EPS of $1.55, beating consensus of $1.48 by 4.7%, and net operating revenue of $1.597B, slightly above the $1.57B consensus. The company raised full-year 2026 guidance for revenue, adjusted EBITDA, and adjusted EPS, and expanded its stock repurchase authorization to $1 billion, reflecting confidence in continued strong operational performance.
- Q2 2026 diluted EPS from continuing operations $1.55 vs consensus $1.48 (beat by 4.7%)
- Net operating revenue $1,597.4M vs consensus $1,570M (beat by 1.7%)
- Revenue grew 9.6% YoY; Adjusted EBITDA grew 9.2% YoY to $348.0M
- Full-year 2026 guidance raised: revenue to $6,410-$6,490M, adjusted EPS to $6.02-$6.25
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access